BEN
45
3
DOV
61
-2
AIG
38
-4
ETR
68
3
GM
65
-3
VTR
49
-3
WDC
41
-2
DE
46
3
XOM
47
5
AMAT
36
5
C
58
-2
IPG
49
10
URBN
38
-4
T
50
3
SIG
43
3
LH
42
2
EQT
59
2
KR
34
-3
AMGN
44
5
TGT
25
-24
BEN
45
3
DOV
61
-2
AIG
38
-4
ETR
68
3
GM
65
-3
VTR
49
-3
WDC
41
-2
DE
46
3
XOM
47
5
AMAT
36
5
C
58
-2
IPG
49
10
URBN
38
-4
T
50
3
SIG
43
3
LH
42
2
EQT
59
2
KR
34
-3
AMGN
44
5
TGT
25
-24
Financhill
Back

XWELL Vs. OncoCyte Industry Stock Comparison

Sell
29

XWEL
XWELL

Last Price:
1.44
Seasonality Move:
-0.35%
Sell
43

OCX
OncoCyte

Last Price:
2.67
Seasonality Move:
36.67%
Sell
29
XWELL (XWEL) is a Sell

Is XWELL a Buy, Sell or Hold?

  • The current XWELL [XWEL] share price is $1.49. The Score for XWEL is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • XWEL is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
OncoCyte (OCX) is a Sell

Is OncoCyte a Buy, Sell or Hold?

  • The current OncoCyte [OCX] share price is $2.75. The Score for OCX is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • OCX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

XWEL Stock Price Chart

What is XWELL's stock price today?

  • The XWELL share price today is $1.49
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and XWEL is experiencing slight selling pressure.

OCX Stock Price Chart

What is OncoCyte's stock price today?

  • The OncoCyte share price today is $2.75
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and OCX is experiencing buying pressure, which is a positive indicator for future bullish movement.

XWEL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.06 Sell
Relative Strength Index (14 RSI): 32.23 Sell
Chaikin Money Flow: -1716 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.63 - 1.81) Sell
Bollinger Bands (100): (1.65 - 1.95) Sell

OCX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.1 Sell
Relative Strength Index (14 RSI): 42.67 Sell
Chaikin Money Flow: 19918 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.77 - 3.11) Sell
Bollinger Bands (100): (2.91 - 3.21) Sell

XWEL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.62 Sell
20-day SMA: 1.7 Sell
50-day SMA: 1.73 Sell
200-day SMA: 1.79 Sell
8-day EMA: 1.6 Sell
20-day EMA: 1.67 Sell
50-day EMA: 1.73 Sell
200-day EMA: 2.07 Sell

OCX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.77 Sell
20-day SMA: 2.89 Sell
50-day SMA: 2.99 Sell
200-day SMA: 2.95 Sell
8-day EMA: 2.74 Buy
20-day EMA: 2.85 Sell
50-day EMA: 2.95 Sell
200-day EMA: 3.21 Sell

XWELL Earnings Growth & XWEL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.26 per share, and a decrease next year of $0.00 per share.

OncoCyte Earnings Growth & OCX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.17 per share, and an increase next year of $0.68 per share.

XWELL Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

OncoCyte Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):